A systematic review on the cardiovascular pharmacology of Gaertn

about

A systematic review on the cardiovascular pharmacology of Gaertn

Item

http://www.wikidata.org/entity/Q58580835

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

A systematic review on the cardiovascular pharmacology of Gaertn

@en

A systematic review on the cardiovascular pharmacology of Gaertn

@nl

type

Item

label

A systematic review on the cardiovascular pharmacology of Gaertn

@en

A systematic review on the cardiovascular pharmacology of Gaertn

@nl

prefLabel

A systematic review on the cardiovascular pharmacology of Gaertn

@en

A systematic review on the cardiovascular pharmacology of Gaertn

@nl

P1476

A systematic review on the cardiovascular pharmacology of Emblica officinalis Gaertn

@en

P2093

Farzaneh Nabati

http://www.w3.org/2001/XMLSchema#string

Fataneh Hashem-Dabaghian

http://www.w3.org/2001/XMLSchema#string

Saeed Kianbakht

http://www.w3.org/2001/XMLSchema#string

Samad Ghaffari

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

The role of nutraceuticals in the prevention of cardiovascular disease.

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research.

Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults.

Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit.

Traditional herbs: a remedy for cardiovascular disorders.

A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin

A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia.

Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.

P304

118-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15171/JCVTR.2018.20

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mojtaba Ziaee

P577

2018-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386531

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6203864

http://www.w3.org/2001/XMLSchema#string